Structure Therapeutics Inc. (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

19.16

+0.42 (2.24%)

At close: Aug 13, 2025, 4:00 PM

18.75

-0.41 (-2.14%)

Pre-market: Aug 14, 2025, 9:03 AM EDT

Structure Therapeutics Employees

Structure Therapeutics had 163 employees as of December 31, 2024. The number of employees increased by 70 or 75.27% compared to the previous year.

Employees

163

Change (1Y)

70

Growth (1Y)

75.27%

Revenue / Employee

n/a

Profits / Employee

-$1,097,853

Market Cap

1.10B

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	163	70	75.27%
Dec 31, 2023	93	25	36.76%
Dec 31, 2022	68	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

GPCR News

7 days ago - Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights - GlobeNewsWire
7 weeks ago - Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671 - GlobeNewsWire
4 months ago - What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday? - Benzinga
5 months ago - Biotech stocks have been hit hard. Why they're a great value now. - Market Watch
5 months ago - Structure: A Lot Riding On Next Data Readout For Oral GLP-1 Candidate - Seeking Alpha
6 months ago - Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences - GlobeNewsWire
7 months ago - Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst - Benzinga
8 months ago - Structure Therapeutics Announces Selection of Lead Oral Small Molecule Amylin Receptor Agonist ACCG-2671 for the Treatment of Obesity - GlobeNewsWire